Compile Data Set for Download or QSAR
maximum 50k data
Found 47 with Last Name = 'blumenstein' and Initial = 'l'
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM102975(US8546435, 3)
Affinity DataIC50:  0.600nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127595(US8791118, 158)
Affinity DataIC50:  1nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127621(US8791118, 195)
Affinity DataIC50:  1nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127620(US8791118, 194)
Affinity DataIC50:  1nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127593(US8791118, 156)
Affinity DataIC50:  1nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127596(US8791118, 159)
Affinity DataIC50:  1nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127597(US8791118, 160)
Affinity DataIC50:  1nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM102976(US8546435, 4)
Affinity DataIC50:  1.30nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM102980(US8546435, 8)
Affinity DataIC50:  1.40nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127598(US8791118, 161)
Affinity DataIC50:  2nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127600(US8791118, 163)
Affinity DataIC50:  2nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127594(US8791118, 157)
Affinity DataIC50:  2nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127601(US8791118, 164)
Affinity DataIC50:  2nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127599(US8791118, 162)
Affinity DataIC50:  2nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM102978(US8546435, 6)
Affinity DataIC50:  3nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127604(US8791118, 167)
Affinity DataIC50:  3nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127624(US8791118, 198)
Affinity DataIC50:  3nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127606(US8791118, 169)
Affinity DataIC50:  3nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127605(US8791118, 168)
Affinity DataIC50:  3nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127603(US8791118, 166)
Affinity DataIC50:  3nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127602(US8791118, 165)
Affinity DataIC50:  3nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM102981(US8546435, 9)
Affinity DataIC50:  3.20nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM102979(US8546435, 7)
Affinity DataIC50:  3.40nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM102977(US8546435, 5)
Affinity DataIC50:  3.40nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127619(US8791118, 189)
Affinity DataIC50:  4nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127592(US8791118, 155)
Affinity DataIC50:  4nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127607(US8791118, 170)
Affinity DataIC50:  4nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127608(US8791118, 171)
Affinity DataIC50:  4nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127622(US8791118, 196)
Affinity DataIC50:  4nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127590(US8791118, 108)
Affinity DataIC50:  4nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127610(US8791118, 173)
Affinity DataIC50:  5nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127609(US8791118, 172)
Affinity DataIC50:  5nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127623(US8791118, 197)
Affinity DataIC50:  5nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127591(US8791118, 127)
Affinity DataIC50:  5nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127615(US8791118, 178)
Affinity DataIC50:  6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127616(US8791118, 179)
Affinity DataIC50:  6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127617(US8791118, 180)
Affinity DataIC50:  6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127618(US8791118, 181)
Affinity DataIC50:  6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127612(US8791118, 175)
Affinity DataIC50:  6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127611(US8791118, 174)
Affinity DataIC50:  6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127614(US8791118, 177)
Affinity DataIC50:  6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127613(US8791118, 176)
Affinity DataIC50:  6nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM102983(US8546435, 17)
Affinity DataIC50:  8.60nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGrowth hormone secretagogue receptor type 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM102982(US8546435, 15)
Affinity DataIC50:  16.5nMAssay Description:Competitive binding assay using ghrelin receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127627(US8791118, 203)
Affinity DataIC50:  24nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127625(US8791118, 201)
Affinity DataIC50:  39nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMitogen-activated protein kinase 1(Homo sapiens (Human))
Aeterna Zentaris

US Patent
LigandPNGBDBM127626(US8791118, 202)
Affinity DataIC50:  41nMpH: 7.5Assay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In DepthDetails US Patent